CG
GMAB icon

Caprock Group’s Genmab GMAB Stock Holding History

Caprock Group’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$249K Sell
9,066
-3,844
-30% -$102K ﹤0.01% 1091
2026
Q1 		$346K Buy
12,910
+3,476
+37% +$104K 0.01% 872
2025
Q4 		$291K Buy
+9,434
New +$294K 0.01% 1012

Other funds holding GMAB

PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Caprock Group's GMAB Position: Q2 2026 in Review

Caprock Group reduced its Genmab (GMAB) stake by 30% in Q2 2026, selling an estimated $102K and leaving 9,066 shares worth $249K. The position accounts for ﹤0.01% of the portfolio, ranked #1091.

Caprock Group first reported a position in GMAB in Q4 2025 and has held it in 3 quarters since. The position peaked at $346K in Q1 2026. 289 funds tracked by Wall St. Rank hold GMAB as of Q2 2026.

  • Caprock Group held 9,066 shares of Genmab worth $249K as of Q2 2026.
  • Caprock Group sold 3,844 Genmab shares in Q2 2026, an estimated $102K.
  • Genmab made up ﹤0.01% of Caprock Group's portfolio in Q2 2026, its #1091 holding.
  • Caprock Group first reported a position in Genmab in Q4 2025 and has held it in 3 quarters since.
  • Caprock Group's Genmab position peaked at $346K in Q1 2026.
  • 289 funds tracked by Wall St. Rank held Genmab as of Q2 2026.

Based on Caprock Group's 13F filing for Q2 2026, filed 27 Jul 2026.